P. Laduron

发表

Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.

J. Leysen, P. Janssen, P A Janssen, 1981, Life sciences.

Pharmacology of New Sleep-Improving Drugs

J. Stutzmann, P. Laduron, J. Blanchard, 1990 .

Riluzole, a glutamate antagonist, enhances slow wave and REM sleep in rats

J. Stutzmann, P. Laduron, J. Blanchard, 1988, Neuroscience Letters.

A serotonergic component of neuroleptic receptors.

J. Leysen, C. Niemegeers, P. Laduron, 1977, Archives internationales de pharmacodynamie et de therapie.

Axonal transport of opiate receptors in capsaicin-sensitive neurones

P. Laduron, 1984, Brain Research.

Specific in vivo binding of neuroleptic drugs in rat brain.

J. Leysen, P. Laduron, 1977, Biochemical pharmacology.

Subcellular distribution of receptor sites in human brain: Differentiation between heavy and light structures of high and low density

D. Scherman, P. Baudhuin, J. Maloteaux, 1995, Brain Research.

Benzodiazepine receptors in normal human brain, in Parkinson's disease and in progressive supranuclear palsy

Y. Agid, F. Javoy‐Agid, J. Maloteaux, 1988, Brain Research.

Different Subcellular Localization of Neurotensin‐Receptor and Neurotensin‐Acceptor Sites in the Rat Brain Dopaminergic System

W. Rostène, P. Laduron, A. Schotte, 1988, Journal of neurochemistry.

Axonal Transport of Dopamine‐containing Vesicles Labelled In Vivo with [3H] Reserpine

D. Scherman, D. Lechardeur, M. Castel, 1993, The European journal of neuroscience.

Inhibition of dopamine receptors in the stomach: an explanation of the gastrokinetic properties of domperidone.

P. Laduron, C. Ennis, J. van Nueten, 1978, Life sciences.

Differential distribution of opiate and neuroleptic receptors and dopamine-sensitive adenylate cyclase in rat brain.

J. Leysen, P. Laduron, 1977, Life sciences.

Symposium on: receptors of dopamine antagonists: new biochemical approaches. July 6-8, 1978, Beerse, Belgium.

J. Leysen, P. Laduron, 1978, Life sciences.

Evidence for a displaceable non-specific [3H]neurotensin binding site in rat brain

J. Leysen, P. Laduron, A. Schotte, 1986, Naunyn-Schmiedeberg's Archives of Pharmacology.

Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution.

W. Rostène, P. Kitabgi, P. Laduron, 1987, European journal of pharmacology.

Retrograde axonal transport of neurotensin in the dopaminergic nigrostriatal pathway in the rat

M. Castel, P. Laduron, C. Malgouris, 1990, Neuroscience.

More binding, more fancy

P. Laduron, 1983 .

Distinction between dopaminergic and serotonergic components of neuroleptic binding sites in limbic brain areas.

J. Leysen, P. Laduron, W. Gommeren, 1979, Biochemical pharmacology.

Presynaptic heteroreceptors in regulation of neuronal transmission.

P. Laduron, 1985, Biochemical pharmacology.

Axoplasmic transport and possible recycling of opiate receptors labelled with 3H-lofentanil.

P. Laduron, P. Janssen, 1982, Life sciences.

Axoplasmic transport of muscarinic receptors

P. Laduron, 1980, Nature.

Down-regulation of 3H-lofentanil binding to opiate receptors in different cultured neuronal cells

J. Maloteaux, P. Laduron, J. Octave, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Light and electron microscopic localization of retrogradely transported neurotensin in rat nigrostriatal dopaminergic neurons

A. Beaudet, J. Woulfe, M. Castel, 1992, Neuroscience.

REGULATION OF μ-OPIATE RECEPTORS IN CULTURED NEURONS

J. Maloteaux, P. Laduron, J. Octave, 1987 .

Axonal transport of the synaptic vesicle monoamine carrier identified by [3H]dihydrotetrabenazine binding in rat sciatic nerve

D. Scherman, P. Laduron, P. Janssen, 1987, Neuroscience Letters.

Chapter 24 Genomic pharmacology: From receptor internalization to nuclear translocation of third messengers

P. Laduron, 1997 .

Solubilisation of high-affinity dopamine receptors

P. Laduron, H. Gorissen, 1979, Nature.

Characterization of solubilized dopamine receptors from dog striatum

P. Laduron, G. Aerts, H. Gorissen, 1979, FEBS letters.

Solubilization of 3H-spiperone binding sites from rat brain.

P. Laduron, H. Gorissen, Pierre M. Laduron, 1978, Life sciences.

From receptor internalization to nuclear translocation. New targets for long-term pharmacology.

P. Laduron, Pierre Laduron, 1994, Biochemical pharmacology.

Activity in QSAR: From A major to A minor

P. Laduron, 1993 .

A non‐peptide NK1‐receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynaptically

P. Laduron, J. Blanchard, C. Garret, 1993, British journal of pharmacology.

HIGH AFFINITY ACCEPTOR SITES IN GUINEA PIG BRAIN FOR [3H]52770 RP, A PAF ANTAGONIST

P. Laduron, J. Blanchard, J. L. Zundel, 1989, Fundamental & clinical pharmacology.

Neuroprotective effects of colchicine in the gerbil model of cerebral ischaemia

J. Stutzmann, P. Laduron, J. Pratt, 1994, Neuroscience Letters.

A rapid assay and partial purification of dopa decarboxylase.

P. Laduron, F. Belpaire, 1968, Analytical biochemistry.

Characterization of an enzyme yielding formaldehyde from‐5‐methyltetrahydrofolic acid

J. Leysen, P. Laduron, 1974, FEBS letters.

Uptake, subcellular distribution and biotransformation of 3H-labelled astemizole in cultured rat hepatocytes.

Y. Schneider, P. Laduron, A. Trouet, 1987, Biochemical pharmacology.

Criteria for receptor sites in binding studies.

P. Laduron, 1984, Biochemical pharmacology.

SPECIFICITY CRITERIA FOR RECEPTOR SITES IN BINDING STUDIES

P. Laduron, 1984 .

RP 62203, a 5-hydroxytryptamine2 antagonist, enhances deep NREM sleep in rats.

J. Stutzmann, P. Laduron, J. Blanchard, 1992, Sleep.

[3H]RP 62203, a ligand of choice to label in vivo brain 5-HT2 receptors.

C. Fajolles, P. Laduron, M. Ponchant, 1992, European journal of pharmacology.

Are 5-HT2 antagonists endowed with anxiolytic properties in rodents?

J. Stutzmann, P. Laduron, J. Blanchard, 1991, Neuroscience Letters.

Stereospecificity in binding studies. A useful criterion though insufficient to prove the presence of receptors.

P. Laduron, 1988, Biochemical pharmacology.

Differential regulation of dopamine-D2 and serotonin-S2 receptors by chronic treatment with the serotonin-S2 antagonists, ritanserin, and setoperone.

J. Leysen, P. Laduron, W. Gommeren, 1987, Psychopharmacology series.

Impact of Janssen drugs for the identification of brain receptors

J. Leysen, P. Laduron, J. van Dun, 1986 .

Chapter 7 – SOLUBILIZATION OF THE DOPAMINE RECEPTOR

P. Laduron, 1984 .

In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.

J. Leysen, P. Laduron, P. Janssen, 1982, European journal of pharmacology.

Solubilized serotonin receptors from rat and dog brain

B. Ilien, P. Laduron, A. Schotte, 1982, FEBS letters.

Brain Dopamine Receptor: Multiple Binding Sites or Physiological Receptor Site

P. Laduron, 1982 .

Solubilization of serotonin receptors from rat frontal Cortex.

B. Ilien, P. Laduron, H. Gorissen, 1980, Biochemical pharmacology.

Differentiation of solubilized dopamine receptors from spirodecanone binding sites in rat striatum

B. Ilien, P. Laduron, G. Aerts, 1980, FEBS letters.

Dopamine receptor: from an in vivo concept towards a molecular characterization

P. Laduron, 1980 .

Characterization of specific in vivo binding of neuroleptic drugs in rat brain.

J. Leysen, P. Laduron, P. Janssen, 1978, Life sciences.

Decay of gerbil electrocorticogramme following reversible bilateral carotid occlusion

J. Stutzmann, P. Laduron, J. Blanchard, 1990 .

Antinociceptive properties and inhibition of neurogenic inflammation with potent SP antagonists belonging to perhydroisoindolones

P. Laduron, J. Peyronel, C. Garret, 1992, Regulatory Peptides.

Agonist-mediated conformational changes of muscarinic receptors in rat brain.

A. Strosberg, G. Vauquelin, P. Laduron, 1982, European journal of biochemistry.

Functional consequences of retrograde axonal transport of receptor-bound neurotensin.

P. Laduron, 1995, Trends in pharmacological sciences.

N-methylation of dopamine to epinine in brain tissue using N-methyltetrahydrofolic acid as the methyl donor.

P. Laduron, 1972, Nature: New biology.

Enhanced axonal transport of receptor-bound opiate in ethanol-treated rats

P. Laduron, P. Witte, 1987, Neuroscience Letters.

Autoradiographic Localization of Retrogradely Transported Neurotensin in Nigrostriatal Neurons

A. Beaudet, J. Woulfe, M. Castel, 1992, Annals of the New York Academy of Sciences.

Axonal transport of receptors: coexistence with neurotransmitter and recycling.

P. Laduron, 1984, Biochemical pharmacology.

Synthesis, anticonvulsant and neuroprotective activities of RP 66055, a riluzole derivative.

P. Laduron, C. Malgouris, A. Doble, 1994, Bioorganic & medicinal chemistry.

Riluzole prevents hyperexcitability produced by the mast cell degranulating peptide and dendrotoxin I in the rat.

C. Gottesmann, G. Böhme, J. Stutzmann, 1991, European journal of pharmacology.

Scope and limitation in dopamine β-hydroxylase measurement

P. Laduron, 1975 .

Scope and limitation in dopamine beta-hydroxylase measurement.

P. Laduron, 1975, Biochemical Pharmacology.

In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole.

J. Leysen, P. Laduron, W. Gommeren, 1982, Molecular pharmacology.

Riluzole series. Synthesis and in vivo "antiglutamate" activity of 6-substituted-2-benzothiazolamines and 3-substituted-2-imino-benzothiazolines.

S. Mignani, P. Hubert, J. Stutzmann, 1999, Journal of medicinal chemistry.

Internalization and intracellular mobilization of neurotensin in neuronal cells.

A. Beaudet, P. Kitabgi, M. Castel, 1994, Biochemical pharmacology.

Preparation and characterization of antisera and monoclonal antibodies to haloperdol

M. Bolger, D. Linthicum, P. Laduron, 1985 .

Specific effect of haloperidol on dopamine turnover in the frontal cortex

J. Leysen, P. Laduron, K. D. Bie, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pharmacology and Biochemistry of Haloperidol

C. Niemegeers, P. Laduron, 1976, Proceedings of the Royal Society of Medicine.

Limiting factors in the antagonism of neuroleptics on dopamine‐sensitive adenylate cyclase

P. Laduron, 1976, The Journal of pharmacy and pharmacology.

Effects of some derivatives of 2-aminotetralin on dopamine-sensitive adenylate cyclase and on the binding of (3H)haloperidol to neuroleptic receptors in the rat striatum.

J. Leysen, B. Costall, R. Naylor, 1978, Biochemical pharmacology.

TPP+ accumulation in rat brain synaptosomes as a probe for Na+ channels.

P. Pauwels, P. Laduron, 1986, European journal of pharmacology.

Ontogenetic development of a 5-methyltetrahydrofolate requiring enzyme in rats and mice

J. Leysen, P. Laduron, G. Aerts, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Tissue fractionation in rat brain, kidney and liver. I. Intracellular localization of a 5-methyltetrahydrofolic acid requiring enzyme.

P. Laduron, W. Gommeren, P. Janssen, 1975, Biochimie.

Enzymatic formaldehyde production from 5-methyltetrahydrofolic acid: prior step to alkaloid formation.

J. Leysen, P. Laduron, 1975, Biochemical pharmacology.

Identification of alkaloids; the condensation products of biogenic amines with formaldehyde, enzymatically formed from 5-methyltetrahydrofolic acid.

J. Leysen, P. Laduron, W. Lauwers, 1975, Biomedical mass spectrometry.

N-methylation of biogenic amines. I. Characterization and properties of an N-methyltransferase in rat brain using 5-methyltetrahydrofolic acid as the methyl donor.

J. Leysen, P. Laduron, W. Gommeren, 1974, Biochemical pharmacology.

NEW CONCEPTS ON THE N-METHYLATION REACTIONS OF BIOGENIC AMINES IN ADRENAL MEDULLA AND BRAIN

P. Laduron, 1973 .

New indole derivatives as potent and selective serotonin uptake inhibitors.

S. Mignani, P. Laduron, C. Gueremy, 1993, Journal of medicinal chemistry.

Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia

J. Stutzmann, P. Laduron, J. Blanchard, 1992, Neuroscience Letters.

Axonal transport of neuroreceptors: Possible involvement in long-term memory

P. Laduron, 1987, Neuroscience.

Pharmacological properties of a potent and selective nonpeptide substance P antagonist.

P. Laduron, J. Blanchard, J. Peyronel, 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.

J. Leysen, C. Niemegeers, P. Laduron, 1982, Molecular pharmacology.

Evidence for a localization of dopamine‐β‐hydroxylase within the chromaffin granules

P. Laduron, 1975, FEBS letters.

Tissue fractionation and catecholamines. I. Latency and activation properties of dopamine-beta-hydroxylase in adrenal medulla.

P. Laduron, F. Belpaire, Frans Belpaire, 1968, Biochemical pharmacology.

Transport of noradrenaline and dopamine-β-hydroxylase in sympathetic nerves

P. Laduron, F. Belpaire, 1968 .

DIFFERENTIAL ACCUMULATION OF ENZYMES IN CONSTRICTED NERVES ACCORDING TO THEIR SUBCELLULAR LOCALIZATION

P. Laduron, 1974 .

Axonal transport of muscarinic receptors in vesicles containing noradrenaline and dopamine‐β‐hydroxylase

P. Laduron, 1984, FEBS letters.

Tissue fractionation and catecholamines. II. Intracellular distribution patterns of tyrosine hydroxylase, dopa decarboxylase, dopamine-beta-hydroxylase, phenylethanolamine N-methyltransferase and monoamine oxidase in adrenal medulla.

P. Laduron, F. Belpaire, Frans Belpaire, 1968, Biochemical pharmacology.

Tissue fractionation and catecholamines —IV. Adenosine triphosphatase in chromaffin granules: A distribution artefact

P. Laduron, G. Aerts, K. D. Bie, 1976, Neuroscience.

Differential Effects of Potassium Channel Blockers on Dopamine Release from Rat Striatal Slices

V. Olivier, P. Laduron, A. Doble, 1991, The Journal of pharmacy and pharmacology.

Structure‐linked latency of muscarinic receptors in axonal transport

P. Laduron, T. Scholtus, Thierry Scholtus, 1986, FEBS letters.

Tissue fractionation and catecholamines. 3. Intracellular distribution of endogenous inhibitors of dopamine- -hydroxylase in adrenal medulla.

P. Laduron, F. Belpaire, 1968, Biochemical pharmacology.

Storage of labeled noradrenaline in lysosomes

P. Laduron, F. Belpaire, W. P. Potter, 1966 .

In vivo formation of epinine in adrenal medulla

J. Leysen, P. Laduron, P. Gompel, 1974, Naunyn-Schmiedeberg's Archives of Pharmacology.

Effect of ATP upon dopamine-β-hydroxylase

P. Laduron, 1975 .

N-methylation of dopamine to epinine in adrenal medulla and brain: A new concept for the biosynthesis of adrenaline and possible implication in schizophrenia

P. Laduron, 1973 .

Evidence for an Extragranular Localization of Tyrosine Hydroxylase

P. Laduron, F. Belpaire, 1968, Nature.

Axonal Transport of Receptors A Major Criterion for Presynaptic Localization

M. Castel, P. Laduron, 1990, Annals of the New York Academy of Sciences.

Axonal transport of receptors: characterization, role in receptor regulation and possible involvement in learning.

P. Laduron, 1987, Journal of receptor research.

Impaired axonal transport of opiate and muscarinic receptors in streptozocin-diabetic rats

P. Laduron, P. Janssen, 1986, Brain Research.

Retrograde axonal transport of receptor-bound opiate in the vagus and delayed accumulation in the nodose ganglion

P. Laduron, P. Janssen, 1985, Brain Research.

Short‐term disappearance of muscarinic cell surface receptors in carbachol‐induced desensitization

P. Pauwels, J. Maloteaux, P. Laduron, 1983, FEBS letters.

STEREOSPECIFIC IN VlTRO BINDING OF [3H]DEXETIMIDE TO BRAIN MUSCARINIC RECEPTORS

J. Leysen, P. Laduron, M. Ver Wimp, 1979, Journal of neurochemistry.

Dopaminergic potency of apomorphine homologues in mice with unilateral lesions of the caudate nucleus

J. Leysen, P. Laduron, 2011 .

Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.

J. Leysen, P. Laduron, W. Gommeren, 1985, Molecular pharmacology.

Domperidone, a novel and safe gastrokinetic anti-nauseant for the treatment of dyspepsia and vomiting.

C. Niemegeers, J. Heykants, K. Schellekens, 1978, Arzneimittel-Forschung.

Differential effects of the isomers of tetramisole on adrenergic neurotransmission in cutaneous veins of dog.

P. Vanhoutte, P. Laduron, T. Verbeuren, 1977, The Journal of pharmacology and experimental therapeutics.

Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding.

J. Leysen, P. Laduron, W. Gommeren, 1978, Biochemical pharmacology.

Spiperone: a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs.

J. Leysen, P. Laduron, P. Janssen, 1978, Biochemical pharmacology.

Muscarinic receptor: multiple sites or unitary concept?

J. Leysen, P. Laduron, H. Gorissen, 1981, Archives internationales de pharmacodynamie et de therapie.

IL-1β-like Freund's adjuvant enhances axonal transport of opiate receptors in sensory neurons

J. Maloteaux, A. Jeanjean, P. Laduron, 1994, Neuroscience Letters.

Differentiation of opiate and neuroleptic receptor binding in rat brain.

J. Leysen, P. Laduron, M. Koch, 1977, European journal of pharmacology.

Studies in organic mass spectrometry. XV. Mass fragmentographic identification of epinine in adrenal medulla and as a product of an in vitro enzymic methylation.

J. Leysen, M. Claeys, P. Laduron, 1974, Biomedical mass spectrometry.

71 – DOMPERIDONE, A NOVEL GASTROKINETIC AND ANTI-NAUSEANT DRUG, INTERACTS SELECTIVELY WITH DOPAMINE RECEPTORS

J. Leysen, P. Laduron, 1978 .

Postnatal ontogeny of the rat brain neurotensin receptor mRNA

J. Maloteaux, E. Hermans, A. Jeanjean, 1993, Neuroscience Letters.

Rapid agonist-induced decrease of neurotensin receptors from the cell surface in rat cultured neurons.

J. Maloteaux, P. Laduron, J. Octave, 1991, Biochemical pharmacology.

Interaction of the substance P receptor antagonist RP 67580 with the rat brain NK1 receptor expressed in transfected CHO cells.

J. Maloteaux, E. Hermans, L. Pradier, 1993, European journal of pharmacology.

Different postnatal ontogeny of two [3H]neurotensin binding sites in rat brain

P. Laduron, A. Schotte, 1987, Brain Research.

Genomic pharmacology: more intracellular sites for drug action.

P. Laduron, 1992, Biochemical pharmacology.

[3H]Batrachotoxinin A 20-alpha-benzoate binding to sodium channels in rat brain: characterization and pharmacological significance.

J. Leysen, P. Pauwels, P. Laduron, 1986, European journal of pharmacology.

Ethanol and opiate decrease the axonal transport of substance-P like immunoreactive material in rat vagus-nerves

M. Hamon, A. Mauborgne, P. Laduron, 1990, Neuropeptides.

Towards Genomic Pharmacology: From Membranal to Nuclear Receptors

P. Laduron, 1992 .

Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity.

J. Leysen, P. Laduron, Josée E. Leysen, 1979, Biochemical pharmacology.

Solubilization of muscarinic acetylcholine receptors from mammalian brain: an analytical approach.

B. Ilien, P. Laduron, G. Aerts, 1981, Analytical biochemistry.

Tissue fractionation in neurobiochemistry: an analytical tool or a source of artifacts.

P. Laduron, 1977, International review of neurobiology.

Characterization of digitonin‐solubilized muscarinic receptor from rat brain

P. Laduron, G. Aerts, H. Gorissen, 1978, FEBS letters.

Retrograde axonal transport of neurotensin in rat nigrostriatal dopaminergic neurons. Modulation during ageing and possible physiological role.

A. Beaudet, M. Castel, P. Laduron, 1994, Biochemical pharmacology.

Reduction of the amount of neurotensin retrogradely transported in dopaminergic neurons of senescent rats

D. Lechardeur, M. Castel, P. Laduron, 1991, Neuroscience Letters.

N-methylation of indolealkylamines in the brain with a new methyl donor.

J. Leysen, P. Laduron, 1974, Advances in biochemical psychopharmacology.

Pharmacology and biochemistry of bromperidol.

C. Niemegeers, P. Laduron, P. Janssen, 1978, Acta psychiatrica Belgica.

Characterization of solubilized serotonin (S2) receptors in rat brain.

B. Ilien, P. Laduron, H. Gorissen, 1982, Molecular pharmacology.

Spiperone: a ligand of choice for neuroleptic receptors. 3. Subcellular distribution of neuroleptic drugs and their receptors in various rat brain areas.

J. Leysen, P. Laduron, P. Janssen, 1978, Biochemical pharmacology.

Subcellular distribution of catecholamines in dog spleen.

P. Laduron, A. D. De Schaepdryver, W. De Potter, 1966, Life sciences.

Differential accumulation of various enzymes in constricted sciatic nerves.

P. Laduron, 1970, Archives internationales de pharmacodynamie et de therapie.

Subcellular localization of dopamine-sensitive adenylate cyclase in rat brain striatum.

J. Leysen, P. Laduron, P. Janssen, 1976, Life sciences.

Characterization and regional distribution of serotonin S2-receptors in human brain

J. Maloteaux, P. Laduron, A. Schotte, 1983, Brain Research.

RP 62203, a naphtosultam derivative with potent and selective 5-HT2 antagonist properties III. Autoradiographic studies

P. Laduron, C. Malgouris, A. Doble, 1990 .

Symposium on: Receptors of dopamine antagonists: New biochemical approaches: July 6–8, 1978 Beerse, Belgium

J. Leysen, P. Laduron, 1978 .

Narcotic withdrawal like mouse jumping produced by amphetamine and L-DOPA.

F. Colpaert, H. Lal, P. Laduron, 1975, European journal of pharmacology.

Opiate receptors in brain labelled in vivo with [3H]lofentanil

P. Laduron, P. Janssen, J. Poncet, 1985, Neuropharmacology.

Dopamine Receptors and Neuroleptic Drugs

P. Laduron, 1989 .

Lack of direct evidence for adrenergic and dopaminergic autoreceptors

P. Laduron, 1984 .

A possible role of lysosomal accumulation in constricted sciatic nerves.

P. Laduron, 1970, Acta Physiologica Scandinavica Supplementum.

Axonal transport of Na+,K+-ATPase identified as a ouabain binding site in rat sciatic nerve

M. Lazdunski, A. Lombet, P. Laduron, 1986, Neuroscience Letters.

Axonal transport of the voltage-dependent Na+ channel protein identified by its tetrodotoxin binding site in rat sciatic nerves

M. Lazdunski, A. Lombet, P. Laduron, 1985, Brain Research.

From monotherapy to multiple drug therapy through long-term pharmacology

P. Laduron, 1997 .

In vivo determination of the profile of benzodiazepine ligands by comparing the inhibition of 3H-Ro 15-1788 binding to the modulation of cGMP levels in mouse cerebellum.

G. Farges, P. Laduron, J. Blanchard, 1988, Biochemical pharmacology.

Solubilization of serotonin S2-receptors from human brain.

J. Maloteaux, P. Laduron, A. Schotte, 1984, European journal of pharmacology.

Neurotensin increases tyrosine hydroxylase messenger RNA-positive neurons in substantia nigra after retrograde axonal transport

M. Castel, P. Laduron, M. Burgevin, 1992, Neuroscience.

Solubilization of brain muscarinic, dopaminergic and serotonergic receptors: a critical analysis.

B. Ilien, P. Laduron, 1982, Biochemical pharmacology.

Effect of gamma-butyrolactone on the retrograde axonal transport of neurotensin in dopaminergic neurones.

M. Castel, P. Laduron, A. Boireau, 1990, European journal of pharmacology.

Receptor binding properties in vitro and in vivo of some long-acting opiates.

J. Leysen, P. Laduron, 1978, Archives internationales de pharmacodynamie et de therapie.

Riluzole antagonizes the anxiogenic properties of the β-carboline FG 7142 in rats

J. Stutzmann, P. Laduron, J. Blanchard, 2004, Psychopharmacology.

Effects of ketoprofen in adjuvant-Induced arthritis measured in a new telemetric model test

P. Laduron, B. Terlain, M. Guillet, 1990 .

Polyclonal antibodies against the rat NK1 receptor: characterization and localization in the spinal cord.

B. Bonici, F. Guinet, P. Laduron, 1992, Neuroreport.

Rp 60180, a new phenothiazine with high affinity for opiate kappa binding sites in animal and human brain

P. Laduron, C. Garret, O. Flamand, 1990 .

[3H]Desipramine and [3H]imipramine binding are not associated with noradrenaline and serotonin uptake in the brain.

P. Laduron, A. Schotte, M. Robbyns, 1982, European journal of pharmacology.

Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils

A. Uzan, P. Laduron, C. Malgouris, 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Regional and Cortical Laminar Distributions of Serotonin S2, Benzodiazepine, Muscarinic, and Dopamine D2 Receptors in Human Brain

J. Maloteaux, P. Laduron, J M Maloteaux, 1984, Journal of neurochemistry.

FURTHER CHARACTERIZATION OF TWO 3H-NEUROTENSIN BINDING SITES IN RAT BRAIN

P. Laduron, A. Schotte, 1987 .

Identification of the serotonin‐S2 receptor ligand binding site by photoaffinity labelling with 7‐azido‐8‐[125I]ketanserin ([125I]AZIK)

P. Laduron, J. van Dun, W. Wouters, 1987, FEBS letters.

Decrease of serotonin‐S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy

Y. Agid, F. Javoy‐Agid, J. Maloteaux, 1988, Movement disorders : official journal of the Movement Disorder Society.